Return Stacked Global Stocks & Bonds ETF (BATS:RSSB – Get Free Report) saw a large decline in short interest during the month of October. As of October 15th, there was short interest totaling 71,606 shares, a decline of 34.2% from the September 30th total of 108,798 shares. Based on an average daily trading volume, of 54,190 shares, the short-interest ratio is presently 1.3 days. Approximately 0.6% of the shares of the stock are short sold.
Return Stacked Global Stocks & Bonds ETF Trading Up 0.2%
BATS:RSSB opened at $29.87 on Tuesday. The stock has a 50 day moving average of $30.31 and a two-hundred day moving average of $29.81. Return Stacked Global Stocks & Bonds ETF has a 12 month low of $26.30 and a 12 month high of $32.29. The firm has a market cap of $498.23 million, a P/E ratio of 19.25 and a beta of 1.02.
Institutional Inflows and Outflows
An institutional investor recently bought a new position in Return Stacked Global Stocks & Bonds ETF stock. Nicholas Hoffman & Company LLC. acquired a new stake in Return Stacked Global Stocks & Bonds ETF (BATS:RSSB – Free Report) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 66,517 shares of the company’s stock, valued at approximately $1,810,000. Nicholas Hoffman & Company LLC. owned approximately 0.59% of Return Stacked Global Stocks & Bonds ETF as of its most recent filing with the Securities and Exchange Commission.
About Return Stacked Global Stocks & Bonds ETF
The Return Stacked Global Stocks & Bonds ETF (RSSB) is an exchange-traded fund that mostly invests in target outcome asset allocation. The fund seeks long-term capital appreciation by holding global equities and US Treasury futures. The fund uses leverage to stack the total return of its equity holdings with the potential returns of the futures contracts RSSB was launched on Dec 4, 2023 and is issued by Return Stacked.
See Also
- Five stocks we like better than Return Stacked Global Stocks & Bonds ETF
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AI—These 5 Stocks Are Getting Paid
Receive News & Ratings for Return Stacked Global Stocks & Bonds ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Return Stacked Global Stocks & Bonds ETF and related companies with MarketBeat.com's FREE daily email newsletter.
